Intco Medical Technology Co., Ltd. (SHE:300677)
China · Delayed Price · Currency is CNY 55.09
+0.09 (0.16%)
Sep 14, 2026, 3:04 PM CST
Intco Medical Technology Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 11,921 | 9,926 | 9,523 | 6,919 | 6,614 | 16,240 |
Revenue Growth | 20.12% | 4.23% | 37.65% | 4.61% | -59.27% | 17.37% |
Gross Profit Gross Profit Growth | 3,837 | 2,374 | 2,176 | 942.35 | 837.65 | 9,973 |
Operating Income Operating Income Growth | 2,164 | 909 | 901.75 | -162.49 | -70.28 | 8,583 |
Net Income Net Income Growth | 1,138 | 1,011 | 1,465 | 383 | 629.07 | 7,430 |
Earnings Per Share EPS Growth | 1.75 | 1.57 | 2.26 | 0.58 | 0.95 | 11.00 |
EPS Growth | -29.42% | -30.53% | 289.65% | -38.95% | -91.36% | -2.73% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Personal Protection Personal Protection Growth | 8,835 | 8,600 | 6,180 | 6,005 | 15,807 |
Rehabilitation Nursing Category Rehabilitation Nursing Category Growth | 447.87 | 457.67 | 395.79 | 377.81 | 254.73 |
Other Other Growth | 642.77 | 465.51 | 343.1 | 230.95 | 177.91 |
Total Total Growth | 9,926 | 9,523 | 6,919 | 6,614 | 16,240 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 15,130 | 13,191 | 18,751 | 13,181 | 8,270 | 8,277 |
Total Debt Total Debt Growth | 17,479 | 17,501 | 13,269 | 7,166 | 1,580 | 292.05 |
Net Cash (Debt) Net Cash Growth | -2,349 | -4,310 | 5,482 | 6,015 | 6,689 | 7,985 |
Net Cash Growth | - | - | -8.86% | -10.08% | -16.23% | 30.68% |
Net Cash Per Share Net Cash Per Share Growth | -3.62 | -6.69 | 8.45 | 9.11 | 10.10 | 11.82 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 2,897 | 1,885 | 1,079 | 502.41 | 1,065 | 8,680 |
Capital Expenditures CapEx Growth | -1,908 | -2,575 | -1,789 | -1,439 | -1,715 | -5,444 |
Free Cash Flow Free Cash Flow Growth | 989.2 | -689.72 | -710.37 | -936.28 | -649.76 | 3,236 |
Free Cash Flow Growth | - | - | - | - | - | -43.12% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 32.18% | 23.91% | 22.85% | 13.62% | 12.67% | 61.41% |
Operating Margin | 18.15% | 9.16% | 9.47% | -2.35% | -1.06% | 52.85% |
Pretax Margin | 12.50% | 12.39% | 16.89% | 6.40% | 10.65% | 53.26% |
Profit Margin | 9.54% | 10.18% | 15.39% | 5.54% | 9.51% | 45.75% |
FCF Margin | 8.30% | -6.95% | -7.46% | -13.53% | -9.82% | 19.93% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.150 | 0.150 | 0.150 | 0.080 | 0.099 | 0.625 |
Dividend Per Share Growth | 33.33% | 0% | 87.50% | -19.00% | -84.20% | -66.25% |
Dividend Yield | 0.28% | 0.39% | 0.60% | 0.35% | 0.48% | 1.35% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 31.41 | 24.95 | 11.07 | 40.01 | 22.05 | 4.28 |
Forward PE | 14.59 | 15.83 | 11.93 | 1.46 | 1.46 | 5.01 |
P/FCF Ratio | 36.07 | - | - | - | - | 9.83 |
PS Ratio | 2.99 | 2.54 | 1.70 | 2.22 | 2.10 | 1.96 |